Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
Sipes directs CDER Regulatory Policy; non-HFC propellant in Dr. Smith’s sprays; Bayer prioritizes health care investment; EMA oversight switch criticized; marketing, development changes At GNC; Pharmavite hires Kellogg, NBTY execs; and ‘Turtle Power’ for Colgate Kids Mouthwash.
You may also be interested in...
People In Brief: Maves at USP, Toll at Pharmavite, Lacik heads Reckitt North America
Maves is USP’s development SVP; Pharmavite takes on Toll as sales exec; Lacik shifts to head Reckitt North America; Rainbow Light adds marketing and sales VPs; Lelinski heads Walgreens health and wellness; more People In Brief.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.